Delivery Order SPE2DB22D2009-SPE2DB24FL8RG
Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The $1,352.16 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,352.73 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of February 12, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,541.59 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a type of pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen Drug Corp is a large pharmaceutical distributor that has been awarded numerous government contracts, including Indefinite Delivery Contracts...
- This federal contract award, valued at $4,001.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product, with an ultimate completion date of April 23, 2024. This is a firm fixed-price delivery order contract, awarded without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,815.13 and an ultimate completion date of May 29, 2025. The contract provides for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, to the government. This award is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,230.62 firm fixed price delivery order is for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical supplies. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.86 firm fixed-price delivery order is for the GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML product, with a completion date of June 14, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,200.94, is a delivery order for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML and has an ultimate completion date of April 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the parent company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order valued at $1,093.56 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty medication, with an ultimate completion date of December 9, 2024. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,482.36, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 27, 2025. The contract does not have a set-aside designation, indicating open competition....